SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Shares Down 1.2% – Time to Sell?

SWEDISH ORPHAN/S (OTCMKTS:SWTUY)’s stock price fell 1.2% on Tuesday . The stock traded as low as $24.38 and last traded at $24.38. Approximately 200 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.

SWEDISH ORPHAN/S Trading Down 1.2%

The company has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a P/E/G ratio of 1.30 and a beta of 1.81. The stock’s 50-day moving average is $24.38 and its 200-day moving average is $24.38.

SWEDISH ORPHAN/S Company Profile

Swedish Orphan Biovitrum AB (publ) (OTCMKTS:SWTUY) is a Stockholm-based biopharmaceutical company specializing in the development, manufacturing and commercialization of therapies for rare diseases and specialty care. The company’s portfolio spans treatments in hematology, immunology and metabolic disorders. Its research and development efforts focus on addressing unmet medical needs by advancing both proprietary and in-licensed drug candidates through clinical and regulatory pathways.

The company’s flagship offerings include clotting factor products for hemophilia, enzyme replacement therapies for lysosomal storage disorders and targeted immunomodulators for inflammatory conditions.